APLM
Apollomics Inc.
$14.31
+4.42%
$31.4M
No data for this timeframe.
Vol
Market Cap$31.4M
Cap SizeNano Cap
SEC Reports1
Recent Activity
May 17, 2026
Insider
Huang Ya-Chi acquired via exercise 500 shares
Director
Apr 27, 2026
SEC
Apollomics reported its 2025 full-year financial results, posting $8.5M in revenue from a licensing deal with LaunXP, a
PRESS-RELEASE — Impact 7/10
Apr 27, 2026
earnings
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
<p>FOSTER CITY, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/
Mar 31, 2026
Insider
LIN PETER KUAN-HOW surrendered for taxes 3,582 shares
Chief Financial Officer @ $15.85 ($56.8K)
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 8, 2024 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| Apr 1, 2024 | EF Hutton | MAINTAIN | Buy → Buy |
| Apr 1, 2024 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| Nov 20, 2023 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Oct 3, 2023 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 17, 2026 | Huang Ya-Chi | M | $0.00 |
| Mar 31, 2026 | LIN PETER | F | $56.8K |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
2 unique insiders with 2 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 17, 2026 | Huang Ya-Chi | Director | EXERCISE | 500 | — | — |
| Mar 31, 2026 | LIN PETER KUAN-HOW | Chief Financial Officer | TAX W/H | 3,582 | $15.85 | $56.8K |
1 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action May 2024): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2024-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2024-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 2 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 8, 2024 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Apr 1, 2024 | EF Hutton | MAINTAIN | Buy | Buy |
| Apr 1, 2024 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Nov 20, 2023 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Oct 3, 2023 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Jun 5, 2023 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jun 1, 2023 | HC Wainwright & Co. | INITIATE | — | Buy |
| Apr 25, 2023 | EF Hutton | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Dec 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Nov 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Oct 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Sep 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Apr 27, 2026
earnings
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
<p>FOSTER CITY, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=izxkXWzOHUxYAEZ4qIXzYKNJN17xHzjbedxZO